Heron Therapeutics, Inc.
Symbol: HRTX (NASDAQ)
1.25
▼ (-3.49%) -0.045
Company Description:
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Key Stats
- Today's Open: $1.28
- Today's High: $1.315
- Today's Low: $1.225
- Today's Volume: 2.52M
- Yesterday Close: $1.29
- Yesterday High: $1.3
- Yesterday Low: $1.22
- Yesterday Volume: 2.47M
- Last Min Volume: 20
- Last Min High: $1.245
- Last Min Low: $1.245
- Last Min VWAP: $1.245
Company Profile
- Name: Heron Therapeutics, Inc.
- Website: https://www.herontx.com
- Listed Date: 1987-08-27
- Location: SAN DIEGO, CA
- Market Status: Active
- CIK Number: 0000818033
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $225.48M
- Round Lot: 100
- Outstanding Shares: 183.31M
- Asset Type: CS
RECENT FILINGS FOR HRTX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-19 | DEF 14A | View |
| 2025-09-16 | EFFECT | View |
| 2025-09-16 | EFFECT | View |
| 2025-09-09 | S-3 | View |
| 2025-09-09 | S-3 | View |
| 2025-09-09 | PRE 14A | View |
| 2025-08-28 | 8-K | View |
| 2025-08-15 | 8-A12B | View |
| 2025-08-15 | 8-K | View |
| 2025-08-12 | SCHEDULE 13D/A | View |
| 2025-08-12 | 4 | View |
| 2025-08-12 | 4 | View |
| 2025-08-12 | 8-K | View |
| 2025-08-12 | 8-K | View |
| 2025-08-08 | 10-Q | View |
| 2025-08-08 | 8-K | View |
| 2025-08-04 | 4 | View |
| 2025-08-04 | 4 | View |
| 2025-08-04 | 4 | View |
| 2025-07-22 | 4 | View |
Latest News on HRTX